Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Advancing Translational Science for Pulmonary NTM Infections: A Roadmap for Research.

Daniel-Wayman S, Abate G, Barber DL, Bermudez LE, Coler RN, Cynamon MH, Daley CL, Davidson RM, Dick T, Floto RA, Henkle E, Holland SM, Jackson M, Lee RE, Nuermberger EL, Olivier KN, Ordway DJ, Prevots DR, Sacchettini JC, Salfinger M, Sassetti CM, Sizemore CF, Winthrop KL, Zelazny AM.

Am J Respir Crit Care Med. 2018 Nov 14. doi: 10.1164/rccm.201807-1273PP. [Epub ahead of print]

PMID:
30428263
2.

Hospital-based antibiotic use in patients with Mycobacterium avium complex.

Ricotta EE, Olivier KN, Lai YL, Prevots DR, Adjemian J.

ERJ Open Res. 2018 Nov 2;4(4). pii: 00109-2018. doi: 10.1183/23120541.00109-2018. eCollection 2018 Oct.

3.

Sarcoidosis-Associated Hospitalizations in the United States, 2002-2012.

Wills AB, Adjemian JA, Fontana JR, Steiner CA, Daniel-Wayman S, Olivier KN, Prevots DR.

Ann Am Thorac Soc. 2018 Sep 10. doi: 10.1513/AnnalsATS.201806-401RL. [Epub ahead of print] No abstract available.

PMID:
30199648
4.

Epidemiology of Nontuberculous Mycobacteriosis.

Adjemian J, Daniel-Wayman S, Ricotta E, Prevots DR.

Semin Respir Crit Care Med. 2018 Jun;39(3):325-335. doi: 10.1055/s-0038-1651491. Epub 2018 Aug 2.

PMID:
30071547
5.

Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents.

Kadri SS, Adjemian J, Lai YL, Spaulding AB, Ricotta E, Prevots DR, Palmore TN, Rhee C, Klompas M, Dekker JP, Powers JH 3rd, Suffredini AF, Hooper DC, Fridkin S, Danner RL; National Institutes of Health Antimicrobial Resistance Outcomes Research Initiative (NIH–ARORI).

Clin Infect Dis. 2018 Jul 23. doi: 10.1093/cid/ciy378. [Epub ahead of print]

PMID:
30052813
6.

Norovirus, astrovirus, and sapovirus among immunocompromised patients at a tertiary care research hospital.

Daniel-Wayman S, Fahle G, Palmore T, Green KY, Prevots DR.

Diagn Microbiol Infect Dis. 2018 Oct;92(2):143-146. doi: 10.1016/j.diagmicrobio.2018.05.017. Epub 2018 May 29.

PMID:
29934072
7.

Epidemiology of Pulmonary Nontuberculous Mycobacterial Sputum Positivity in Patients with Cystic Fibrosis in the United States, 2010-2014.

Adjemian J, Olivier KN, Prevots DR.

Ann Am Thorac Soc. 2018 Jul;15(7):817-826. doi: 10.1513/AnnalsATS.201709-727OC.

PMID:
29897781
8.

Seroepidemiology of helminths and the association with severe malaria among infants and young children in Tanzania.

Kwan JL, Seitz AE, Fried M, Lee KL, Metenou S, Morrison R, Kabyemela E, Nutman TB, Prevots DR, Duffy PE.

PLoS Negl Trop Dis. 2018 Mar 26;12(3):e0006345. doi: 10.1371/journal.pntd.0006345. eCollection 2018 Mar.

9.

Hemoglobin variants shape the distribution of malaria parasites in human populations and their transmission potential.

Gonçalves BP, Sagara I, Coulibaly M, Wu Y, Assadou MH, Guindo A, Ellis RD, Diakite M, Gabriel E, Prevots DR, Doumbo OK, Duffy PE.

Sci Rep. 2017 Oct 27;7(1):14267. doi: 10.1038/s41598-017-14627-y.

10.

Geographic Distribution of Nontuberculous Mycobacterial Species Identified among Clinical Isolates in the United States, 2009-2013.

Spaulding AB, Lai YL, Zelazny AM, Olivier KN, Kadri SS, Prevots DR, Adjemian J.

Ann Am Thorac Soc. 2017 Nov;14(11):1655-1661. doi: 10.1513/AnnalsATS.201611-860OC.

11.

A Malaria-Resistant Phenotype with Immunological Correlates in a Tanzanian Birth Cohort Exposed to Intense Malaria Transmission.

Nash SD, Prevots DR, Kabyemela E, Khasa YP, Lee KL, Fried M, Duffy PE.

Am J Trop Med Hyg. 2017 May;96(5):1190-1196. doi: 10.4269/ajtmh.16-0554.

12.

Nontuberculous mycobacterial pulmonary disease: an increasing burden with substantial costs.

Prevots DR, Loddenkemper R, Sotgiu G, Migliori GB.

Eur Respir J. 2017 Apr 26;49(4). pii: 1700374. doi: 10.1183/13993003.00374-2017. Print 2017 Apr. No abstract available.

13.

Long-Term Outcomes in a Population-based Cohort with Respiratory Nontuberculous Mycobacteria Isolation.

Henkle E, Novosad SA, Shafer S, Hedberg K, Siegel SAR, Ku J, Varley C, Prevots DR, Marras TK, Winthrop KL.

Ann Am Thorac Soc. 2017 Jul;14(7):1120-1128. doi: 10.1513/AnnalsATS.201610-801OC.

14.

Epidemiology of Nontuberculous Mycobacterial Lung Disease and Tuberculosis, Hawaii, USA.

Adjemian J, Frankland TB, Daida YG, Honda JR, Olivier KN, Zelazny A, Honda S, Prevots DR.

Emerg Infect Dis. 2017 Mar;23(3):439-447. doi: 10.3201/eid2303.161827.

15.

Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases.

van Ingen J, Wagner D, Gallagher J, Morimoto K, Lange C, Haworth CS, Floto RA, Adjemian J, Prevots DR, Griffith DE; NTM-NET.

Eur Respir J. 2017 Feb 15;49(2). pii: 1601855. doi: 10.1183/13993003.01855-2016. Print 2017 Feb. No abstract available.

16.

Epidemiology of Hospitalizations Associated with Invasive Candidiasis, United States, 2002-20121.

Strollo S, Lionakis MS, Adjemian J, Steiner CA, Prevots DR.

Emerg Infect Dis. 2016 Jan;23(1):7-13. doi: 10.3201/eid2301.161198.

17.

Epidemiology of Norovirus Infection Among Immunocompromised Patients at a Tertiary Care Research Hospital, 2010-2013.

Bok K, Prevots DR, Binder AM, Parra GI, Strollo S, Fahle GA, Behrle-Yardley A, Johnson JA, Levenson EA, Sosnovtsev SV, Holland SM, Palmore TN, Green KY.

Open Forum Infect Dis. 2016 Sep 8;3(3):ofw169. eCollection 2016 Sep.

18.

Patient-Centered Research Priorities for Pulmonary Nontuberculous Mycobacteria (NTM) Infection. An NTM Research Consortium Workshop Report.

Henkle E, Aksamit T, Barker A, Daley CL, Griffith D, Leitman P, Leitman A, Malanga E, Marras TK, Olivier KN, Prevots DR, Prieto D, Quittner AL, Skach W, Walsh JW, Winthrop KL; NTMRC Patient Advisory Panel.

Ann Am Thorac Soc. 2016 Sep;13(9):S379-84. doi: 10.1513/AnnalsATS.201605-387WS.

19.

Mortality among patients with pulmonary non-tuberculous mycobacteria disease.

Fleshner M, Olivier KN, Shaw PA, Adjemian J, Strollo S, Claypool RJ, Folio L, Zelazny A, Holland SM, Prevots DR.

Int J Tuberc Lung Dis. 2016 May;20(5):582-7. doi: 10.5588/ijtld.15.0807.

PMID:
27084809
20.

Long-term Follow-up of Patients With Lyme Disease: Longitudinal Analysis of Clinical and Quality-of-life Measures.

Wills AB, Spaulding AB, Adjemian J, Prevots DR, Turk SP, Williams C, Marques A.

Clin Infect Dis. 2016 Jun 15;62(12):1546-1551. doi: 10.1093/cid/ciw189. Epub 2016 Mar 29.

21.

Preparing for future efficacy trials of severe malaria vaccines.

Gonçalves BP, Prevots DR, Kabyemela E, Fried M, Duffy PE.

Vaccine. 2016 Apr 7;34(16):1865-7. doi: 10.1016/j.vaccine.2016.02.053. Epub 2016 Mar 8.

22.

Reply: Cure Not Possible, by Definition.

Griffith DE, Adjemian J, Brown-Elliott BA, Prevots DR, Philley JV, Olivier KN, Wallace RJ Jr.

Am J Respir Crit Care Med. 2015 Nov 15;192(10):1256-7. doi: 10.1164/rccm.201508-1515LE. No abstract available.

23.

Beyond Marfan: the clinical impact of bronchiectasis and non-tuberculous mycobacteria in connective tissue diseases.

Leung JM, Olivier KN, Prevots DR, McDonnell NB.

Int J Tuberc Lung Dis. 2015 Nov;19(11):1409. doi: 10.5588/ijtld.15.0597. No abstract available.

PMID:
26467599
24.

Clonal Diversification and Changes in Lipid Traits and Colony Morphology in Mycobacterium abscessus Clinical Isolates.

Park IK, Hsu AP, Tettelin H, Shallom SJ, Drake SK, Ding L, Wu UI, Adamo N, Prevots DR, Olivier KN, Holland SM, Sampaio EP, Zelazny AM.

J Clin Microbiol. 2015 Nov;53(11):3438-47. doi: 10.1128/JCM.02015-15. Epub 2015 Aug 19.

25.

The Burden of Pulmonary Nontuberculous Mycobacterial Disease in the United States.

Strollo SE, Adjemian J, Adjemian MK, Prevots DR.

Ann Am Thorac Soc. 2015 Oct;12(10):1458-64. doi: 10.1513/AnnalsATS.201503-173OC.

26.

Semiquantitative Culture Analysis during Therapy for Mycobacterium avium Complex Lung Disease.

Griffith DE, Adjemian J, Brown-Elliott BA, Philley JV, Prevots DR, Gaston C, Olivier KN, Wallace RJ Jr.

Am J Respir Crit Care Med. 2015 Sep 15;192(6):754-60. doi: 10.1164/rccm.201503-0444OC.

27.

Pulmonary Nontuberculous Mycobacterial Infection. A Multisystem, Multigenic Disease.

Szymanski EP, Leung JM, Fowler CJ, Haney C, Hsu AP, Chen F, Duggal P, Oler AJ, McCormack R, Podack E, Drummond RA, Lionakis MS, Browne SK, Prevots DR, Knowles M, Cutting G, Liu X, Devine SE, Fraser CM, Tettelin H, Olivier KN, Holland SM.

Am J Respir Crit Care Med. 2015 Sep 1;192(5):618-28. doi: 10.1164/rccm.201502-0387OC.

28.

Spatial epidemiology of blastomycosis hospitalizations: detecting clusters and identifying environmental risk factors.

Seitz AE, Adjemian J, Steiner CA, Prevots DR.

Med Mycol. 2015 Jun;53(5):447-54. doi: 10.1093/mmy/myv014. Epub 2015 Apr 23.

PMID:
25908653
29.

Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review.

Prevots DR, Marras TK.

Clin Chest Med. 2015 Mar;36(1):13-34. doi: 10.1016/j.ccm.2014.10.002. Epub 2014 Nov 6. Review.

30.

The tolerability of linezolid in the treatment of nontuberculous mycobacterial disease.

Winthrop KL, Ku JH, Marras TK, Griffith DE, Daley CL, Olivier KN, Aksamit TR, Varley CD, Mackey K, Prevots DR.

Eur Respir J. 2015 Apr;45(4):1177-9. doi: 10.1183/09031936.00169114. Epub 2015 Jan 22. No abstract available.

31.

Variable agreement among experts regarding Mycobacterium avium complex lung disease.

Marras TK, Prevots DR, Jamieson FB, Winthrop KL; Pulmonary MAC Outcomes Group.

Respirology. 2015 Feb;20(2):348-51. doi: 10.1111/resp.12440. Epub 2014 Nov 28.

32.

Incidence and trends of blastomycosis-associated hospitalizations in the United States.

Seitz AE, Younes N, Steiner CA, Prevots DR.

PLoS One. 2014 Aug 15;9(8):e105466. doi: 10.1371/journal.pone.0105466. eCollection 2014.

33.

Environmental risks for nontuberculous mycobacteria. Individual exposures and climatic factors in the cystic fibrosis population.

Prevots DR, Adjemian J, Fernandez AG, Knowles MR, Olivier KN.

Ann Am Thorac Soc. 2014 Sep;11(7):1032-8. doi: 10.1513/AnnalsATS.201404-184OC.

34.

Nontuberculous mycobacteria among patients with cystic fibrosis in the United States: screening practices and environmental risk.

Adjemian J, Olivier KN, Prevots DR.

Am J Respir Crit Care Med. 2014 Sep 1;190(5):581-6. doi: 10.1164/rccm.201405-0884OC.

35.

Parasite burden and severity of malaria in Tanzanian children.

Gonçalves BP, Huang CY, Morrison R, Holte S, Kabyemela E, Prevots DR, Fried M, Duffy PE.

N Engl J Med. 2014 May 8;370(19):1799-808. doi: 10.1056/NEJMoa1303944.

36.

Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease.

Olivier KN, Shaw PA, Glaser TS, Bhattacharyya D, Fleshner M, Brewer CC, Zalewski CK, Folio LR, Siegelman JR, Shallom S, Park IK, Sampaio EP, Zelazny AM, Holland SM, Prevots DR.

Ann Am Thorac Soc. 2014 Jan;11(1):30-5. doi: 10.1513/AnnalsATS.201307-231OC.

37.

Lack of adherence to evidence-based treatment guidelines for nontuberculous mycobacterial lung disease.

Adjemian J, Prevots DR, Gallagher J, Heap K, Gupta R, Griffith D.

Ann Am Thorac Soc. 2014 Jan;11(1):9-16. doi: 10.1513/AnnalsATS.201304-085OC.

38.

Cytokine profiles at birth predict malaria severity during infancy.

Kabyemela E, Gonçalves BP, Prevots DR, Morrison R, Harrington W, Gwamaka M, Kurtis JD, Fried M, Duffy PE.

PLoS One. 2013 Oct 10;8(10):e77214. doi: 10.1371/journal.pone.0077214. eCollection 2013.

39.

Opinions differ by expertise in Mycobacterium avium complex disease.

Marras TK, Prevots DR, Jamieson FB, Winthrop KL; Pulmonary MAC Outcomes Group.

Ann Am Thorac Soc. 2014 Jan;11(1):17-22. doi: 10.1513/AnnalsATS.201305-136OC.

40.

Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis.

Binder AM, Adjemian J, Olivier KN, Prevots DR.

Am J Respir Crit Care Med. 2013 Oct 1;188(7):807-12. doi: 10.1164/rccm.201307-1200OC.

41.

Clinical and therapeutic features of pulmonary nontuberculous mycobacterial disease, Brazil, 1993-2011.

de Mello KG, Mello FC, Borga L, Rolla V, Duarte RS, Sampaio EP, Holland SM, Prevots DR, Dalcolmo MP.

Emerg Infect Dis. 2013 Mar;19(3):393-9. doi: http://dx.doi.org/10.3201/eid/1903.120735.

42.

Epidemiology of cryptococcal meningitis in the US: 1997-2009.

Pyrgos V, Seitz AE, Steiner CA, Prevots DR, Williamson PR.

PLoS One. 2013;8(2):e56269. doi: 10.1371/journal.pone.0056269. Epub 2013 Feb 15.

43.

Hospitalizations associated with disseminated coccidioidomycosis, Arizona and California, USA.

Seitz AE, Prevots DR, Holland SM.

Emerg Infect Dis. 2012 Sep;18(9):1476-9. doi: 10.3201/eid1809.120151.

44.

Spatial clusters of nontuberculous mycobacterial lung disease in the United States.

Adjemian J, Olivier KN, Seitz AE, Falkinham JO 3rd, Holland SM, Prevots DR.

Am J Respir Crit Care Med. 2012 Sep 15;186(6):553-8. doi: 10.1164/rccm.201205-0913OC. Epub 2012 Jul 5.

45.

Molecular epidemiology of Neisseria meningitidis serogroup B in Brazil.

de Filippis I, de Lemos AP, Hostetler JB, Wollenberg K, Sacchi CT, Dunning Hotopp JC, Harrison LH, Bash MC, Prevots DR.

PLoS One. 2012;7(3):e33016. doi: 10.1371/journal.pone.0033016. Epub 2012 Mar 14. Erratum in: PLoS One. 2012;7(7): doi/10.1371/annotation/6318254d-3f13-4cca-8bbe-08d0ff29aa64. Dunning Hotopp, Julie C [added].

46.

Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries.

Adjemian J, Olivier KN, Seitz AE, Holland SM, Prevots DR.

Am J Respir Crit Care Med. 2012 Apr 15;185(8):881-6. doi: 10.1164/rccm.201111-2016OC. Epub 2012 Feb 3.

47.

Trends in bronchiectasis among medicare beneficiaries in the United States, 2000 to 2007.

Seitz AE, Olivier KN, Adjemian J, Holland SM, Prevots DR.

Chest. 2012 Aug;142(2):432-439. doi: 10.1378/chest.11-2209.

48.

Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems.

Prevots DR, Shaw PA, Strickland D, Jackson LA, Raebel MA, Blosky MA, Montes de Oca R, Shea YR, Seitz AE, Holland SM, Olivier KN.

Am J Respir Crit Care Med. 2010 Oct 1;182(7):970-6. doi: 10.1164/rccm.201002-0310OC. Epub 2010 Jun 10.

49.

Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006.

Seitz AE, Olivier KN, Steiner CA, Montes de Oca R, Holland SM, Prevots DR.

Chest. 2010 Oct;138(4):944-9. doi: 10.1378/chest.10-0099. Epub 2010 Apr 30.

50.

Nontuberculous mycobacteria-associated lung disease in hospitalized persons, United States, 1998-2005.

Billinger ME, Olivier KN, Viboud C, de Oca RM, Steiner C, Holland SM, Prevots DR.

Emerg Infect Dis. 2009 Oct;15(10):1562-9. doi: 10.3201/eid1510.090196.

Supplemental Content

Loading ...
Support Center